NCT02789475View on ClinicalTrials.gov

DP-R212 Pharmacokinetic Study

PHASE1UnknownINTERVENTIONAL

Enrollment

38

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

HypertensionHyperlipidemias

Interventions

DRUG

Amlodipine

Amlodipine administration

DRUG

Rosuvastatin

Rosuvastatin administration

Trial Locations (1)

400-711

RECRUITING

Inha university hospital, Jung-gu

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alvogen Korea

INDUSTRY